In 2012, the Africa Heads of State through the African Union (AU) endorsed the Pharmaceutical Manufacturing Plan for Africa Business Plan (PMPA BP). The core objective of the PMPA BP is to develop a competitive and enduring integrated pharmaceutical manufacturing industry in Africa, able to respond to the continent’s need for access to secure and reliable supply of quality, safe and efficacious affordable medicines.
By supporting local pharmaceutical manufacturing, the continent will contribute towards: A sustainable supply of quality essential medicines Improved public health outcomes Industrial and economic development.
The vision and objectives of the PMPA BP provide a strong rallying point for WAPMA. In line with the generic solutions identified in the PMPA BP, FAPMA has identified the following priorities that will contribute towards the realisation of both the PMPA BP and the vision of FAPMA:.